Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Boston, Harvard Medical School, Boston, MA 02114, USA.
BMC Neurol. 2010 Feb 10;10:13. doi: 10.1186/1471-2377-10-13.
The stability of hypoperfused brain tissue in stroke patients with major artery occlusions is unknown. The purpose of this study was to determine the persistence of a diffusion/perfusion mismatch in patients with ICA or proximal MCA occlusions.
Fourteen patients with ICA and/or proximal MCA occlusion and a diffusion/perfusion mismatch at presentation were studied. All were enrolled in a pilot randomized study of normobaric oxygen therapy. None received thrombolytic therapy; 8 received normobaric oxygen and 6 room air. Diffusion/perfusion MRI was performed at baseline, 4 hours, 24 hours, and 1 week. Abnormal DWI, ADC, and MTT volumes were determined using standard image analysis methods.
The mean time from symptom onset to baseline MRI was 7.5 +/- 1 hours. Across all 4 time points there was a significant difference in DWI lesion (ANOVA, P < 0.0001) and abnormal MTT volumes (ANOVA, P < 0.01) with the 24 hour and 1 week abnormal volumes different from the earlier studies. However, comparing baseline and 4 hour scans, there was no significant interval change in the mean abnormal DWI volume (29.4 +/- 8.2 ml vs. 28.1 +/- 7.4 ml) or abnormal MTT volumes (137 +/- 17.7 ml vs. 130.9 +/- 13.8). By 24 hours, only 2 patients did not maintain a mismatch of 20% or greater.
Patients who present outside the time window for thrombolytic therapy, and who have a large diffusion/perfusion mismatch on MRI may have a stable mismatch for 4 or more hours.
大脑中动脉闭塞的脑卒中患者低灌注脑组织的稳定性尚不清楚。本研究旨在确定颈内动脉或近端 MCA 闭塞患者存在弥散/灌注不匹配的持续时间。
研究了 14 例颈内动脉和/或近端 MCA 闭塞且在发病时存在弥散/灌注不匹配的患者。所有患者均纳入常压氧疗的先导随机研究。无溶栓治疗者;8 例接受常压氧治疗,6 例接受室内空气治疗。在基线、4 小时、24 小时和 1 周时进行弥散/灌注 MRI。使用标准图像分析方法确定异常 DWI、ADC 和 MTT 体积。
从症状发作到基线 MRI 的平均时间为 7.5 ± 1 小时。在所有 4 个时间点,DWI 病变(方差分析,P < 0.0001)和异常 MTT 体积(方差分析,P < 0.01)均存在显著差异,24 小时和 1 周的异常体积与早期研究不同。然而,与基线和 4 小时扫描相比,异常 DWI 体积(29.4 ± 8.2 ml 与 28.1 ± 7.4 ml)或异常 MTT 体积(137 ± 17.7 ml 与 130.9 ± 13.8 ml)的平均间隔无显著变化。到 24 小时,只有 2 例患者没有维持 20%或更高的不匹配。
发病时间超过溶栓治疗时间窗的患者,且 MRI 上存在大的弥散/灌注不匹配的患者,4 小时或更长时间内可能保持不匹配。